Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immune Therapeutics Inc (OTCQB:IMUN)

0.05
Delayed Data
As of Jul 19
 -0.002 / -3.85%
Today’s Change
0.03
Today|||52-Week Range
0.18
0.00%
Year-to-Date
No recent news for Immune Therapeutics Inc.

Today’s Trading

Previous close0.05
Today’s open0.05
Day’s range0.05 - 0.05
Volume681,672
Average volume (3 months)924,325
Market cap$15.2M
Dividend yield--
Data as of 07/19/2017

Growth & Valuation

Earnings growth (last year)+18.18%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-78.62%
P/E ratio--
Price/Sales3,128.62
Price/Book--

Competitors

No competitors data available.

Financials

Last reporting dateMay 29, 2013
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$3.5K
Annual profit (last year)-$19.5M
Net profit margin-563,713.57%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Noreen Griffin
Chief Financial Officer
Peter J. Aronstam
Corporate headquarters
Orlando, Florida

Forecasts